Learn More
Medchemexpress LLC Romaciclib monohydrochloride | 2443816-41-7 | 99.3% | 450.60 | 50 MG

Supplier: Medchemexpress LLC HY111388A100MG
Romaciclib monohydrochloride is an ATP-competitive and selective CDK8 inhibitor, inhibiting kinase activities of CDK8/CycC and CDK19/CycC complexes. It weakly inhibits CDK9 but shows no obvious activity against CDK1, 2, 4, 6, 5, 7. This compound inhibits phosphorylation of STAT1 S727 and STAT5 S726 and has anti-tumor activity. It is for research use only.
- Inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes.
- Weakly inhibits CDK9.
- Shows no obvious activity against CDK1, 2, 4, 6, 5, 7.
- Inhibits phosphorylation of STAT1 S727 and STAT5 S726.
- Has anti-tumor activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.